Postural tachycardia syndrome and inappropriate sinus tachycardia: role of autonomic modulation and sinus node automaticity

Victor C Nwazue, Sachin Y Paranjape, Bonnie K Black, Italo Biaggioni, André Diedrich, William D Dupont, David Robertson, Satish R Raj, Victor C Nwazue, Sachin Y Paranjape, Bonnie K Black, Italo Biaggioni, André Diedrich, William D Dupont, David Robertson, Satish R Raj

Abstract

Background: Inappropriate sinus tachycardia (IST) and postural tachycardia syndrome (POTS) are 2 disorders characterized by sinus tachycardia. It is debated whether the pathophysiology of IST and POTS results from abnormal autonomic regulation or abnormal sinus node function. We hypothesized that intrinsic heart rate (IHR) after autonomic blockade would be increased in patients with IST but not POTS.

Methods and results: We enrolled 48 POTS patients, 8 IST patients, and 17 healthy control (HC) subjects. Intravenous propranolol and atropine were given to block the sympathetic and parasympathetic limbs of the autonomic nervous system in order to determine the IHR. Patients with IST have a higher sympathetic contribution to heart rate when compared with POTS patients (31±13 bpm versus 12±7 bpm, P<0.001) and HC (8±4 bpm; P<0.001) and a trend to less parasympathetic contribution than POTS and HC (IST: 31±11 bpm versus POTS: 46±11 bpm versus HC: 48±11 bpm, ANOVA P=0.108). IHR was not significantly different between IST and either POTS or HC (IST: 111±11 bpm versus POTS: 108±11 bpm versus HC: 106±12 bpm, ANOVA P=0.237).

Conclusions: IST patients have more sympathetic tone when compared with either POTS or HC, but IST patients do not have abnormal sinus node automaticity. These data suggest that the treatment of IST and POTS should focus on sympatholysis, reserving sinus node modification for patients with continued debilitating symptoms after beta-blockade and possibly ivabradine.

Clinical trial registration url: https://ichgcp.net/clinical-trials-registry/NCT00262470" title="See in ClinicalTrials.gov">NCT00262470.

Keywords: autonomic nervous system; inappropriate sinus tachycardia; postural tachycardia syndrome; sinus node; sympathetic nervous system.

Figures

Figure 1.
Figure 1.
Schematic diagram showing the study design. After a 10‐minute baseline to obtain resting heart rate (HR), subjects were given propranolol in 4 divided doses. This dose was enough to block the parasympathetic arm of the autonomic nervous system. After recording the post‐propranolol HR, atropine was given in 4 divided doses. The resultant HR is the intrinsic HR.
Figure 2.
Figure 2.
Intrinsic heart rate (HR) data is presented after pharmacologic blockade with propranolol and atropine (A). Sympathetic contribution to HR was calculated as the drop in HR with IV propranolol (B), and the parasympathetic contribution to HR was calculated as the increase in HR with IV atropine (C). The error bars represent standard error of the mean. The adjusted ANOVA P values for age and BMI are presented as the overall difference and post‐hoc Bonferroni tests were used to adjust for multiple pair‐wise comparisons. ANOVA indicates analysis of variance; BMI, body mass index; HC, healthy control; IST, inappropriate sinus tachycardia; POTS, postural tachycardia syndrome; PSYM, parasympathetic; SYM, sympathetic.
Figure 3.
Figure 3.
High frequency heart rate variability (RRI‐HF; A) and low frequency systolic blood pressure variability (SBP‐LF; B) are shown. Adjusted ANOVA P values are presented for overall difference and post‐hoc Bonferroni tests were used to adjust for multiple pair‐wise comparisons. ANOVA indicates analysis of variance; HC, healthy control; IST, inappropriate sinus tachycardia; POTS, postural tachycardia syndrome.
Figure 4.
Figure 4.
Schematic cartoon of sinus tachycardia disorders spectrum. Postural tachycardia syndrome (POTS) patients have greater sympathetic tone (SNS) and less parasympathetic tone (PNS) than healthy subjects. Patients with inappropriate sinus tachycardia (IST) patients have even greater SNS tone and lower PNS tone compared to POTS patients.

References

    1. Brady PA, Low PA, Shen WK. Inappropriate sinus tachycardia, postural orthostatic tachycardia syndrome, and overlapping syndromes. Pacing Clin Electrophysiol. 2005; 28:1112-1121
    1. Shen WK, Low PA, Jahangir A, Munger TM, Friedman PA, Osborn MJ, Stanton MS, Packer DL, Rea RF, Hammill SC. Is sinus node modification appropriate for inappropriate sinus tachycardia with features of postural orthostatic tachycardia syndrome? Pacing Clin Electrophysiol. 2001; 24:217-230
    1. Morillo CA, Klein GJ, Thakur RK, Li H, Zardini M, Yee R. Mechanism of ‘inappropriate’ sinus tachycardia. Role of sympathovagal balance. Circulation. 1994; 90:873-877
    1. Olshansky B, Sullivan RM. Inappropriate sinus tachycardia. J Am Coll Cardiol. 2013; 61:793-801
    1. Bauernfeind RA, Amat YL, Dhingra RC, Kehoe R, Wyndham C, Rosen KM. Chronic nonparoxysmal sinus tachycardia in otherwise healthy persons. Ann Intern Med. 1979; 91:702-710
    1. Still AM, Raatikainen P, Ylitalo A, Kauma H, Ikaheimo M, Antero KY, Huikuri HV. Prevalence, characteristics and natural course of inappropriate sinus tachycardia. Europace. 2005; 7:104-112
    1. Raj SR. The postural tachycardia syndrome (POTS): pathophysiology, diagnosis & management. Indian Pacing Electrophysiol J. 2006; 6:84-99
    1. Schondorf R, Low PA. Idiopathic postural orthostatic tachycardia syndrome: an attenuated form of acute pandysautonomia? Neurology. 1993; 43:132-137
    1. Low PA, Sandroni P, Joyner M, Shen WK. Postural tachycardia syndrome (POTS). J Cardiovasc Electrophysiol. 2009; 20:352-358
    1. Harris PA, Scott KW, Lebo L, Hassan N, Lightner C, Pulley J. ResearchMatch: a national registry to recruit volunteers for clinical research. Acad Med. 2012; 87:66-73
    1. Jacob G, Shannon JR, Black B, Biaggioni I, Mosqueda‐Garcia R, Robertson RM, Robertson D. Effects of volume loading and pressor agents in idiopathic orthostatic tachycardia. Circulation. 1997; 96:575-580
    1. Pan J, Tompkins WJ. A real‐time QRS detection algorithm. IEEE Trans Biomed Eng. 1985; 32:230-236
    1. Oppenheimer D. In: Bannister R. (ed.). Neuropathology of autonomic failure. Autonomic Failure. A Textbook of Clinical Disorders of the Autonomic Nervous System. 1988Oxford: Oxford Medical Publications; 451-463
    1. Heart rate variability: standards of measurement, physiological interpretation and clinical use. Task Force of the European Society of Cardiology and the North American Society of Pacing and Electrophysiology. Circulation. 1996; 93:1043-1065
    1. Diedrich A, Jordan J, Tank J, Shannon JR, Robertson R, Luft FC, Robertson D, Biaggioni I. The sympathetic nervous system in hypertension: assessment by blood pressure variability and ganglionic blockade. J Hypertens. 2003; 21:1677-1686
    1. Nerheim P, Birger‐Botkin S, Piracha L, Olshansky B. Heart failure and sudden death in patients with tachycardia‐induced cardiomyopathy and recurrent tachycardia. Circulation. 2004; 110:247-252
    1. Winum PF, Cayla G, Rubini M, Beck L, Messner‐Pellenc P. A case of cardiomyopathy induced by inappropriate sinus tachycardia and cured by ivabradine. Pacing Clin Electrophysiol. 2009; 32:942-944
    1. Lee RJ, Kalman JM, Fitzpatrick AP, Epstein LM, Fisher WG, Olgin JE, Lesh MD, Scheinman MM. Radiofrequency catheter modification of the sinus node for “inappropriate” sinus tachycardia. Circulation. 1995; 92:2919-2928
    1. Jayaprakash S, Sparks PB, Vohra J. Inappropriate sinus tachycardia (IST): management by radiofrequency modification of sinus node. Aust N Z J Med. 1997; 27:391-397
    1. Man KC, Knight B, Tse HF, Pelosi F, Michaud GF, Flemming M, Strickberger SA, Morady F. Radiofrequency catheter ablation of inappropriate sinus tachycardia guided by activation mapping. J Am Coll Cardiol. 2000; 35:451-457
    1. Schuessler RB, Boineau PJ, Saffitz JP, Brpmberg BI, Kwong KF. In: Zipes DP, Jalife J. (eds.). Cellular mechanisms of sinoatrial activity. Cardiac Electrophysiology: From Cell to Bedside. 20003rd edSaunders: Philadelphia; 187-195
    1. Kimura T, Uchida W, Satoh S. Predominance of postsynaptic mechanism in vagal suppression of sympathetic tachycardia in the dog. J Pharmacol Exp Ther. 1985; 235:793-797
    1. DiFrancesco D, Ferroni A, Mazzanti M, Tromba C. Properties of the hyperpolarizing‐activated current (if) in cells isolated from the rabbit sino‐atrial node. J Physiol. 1986; 377:61-88
    1. Chiale PA, Garro HA, Schmidberg J, Sanchez RA, Acunzo RS, Lago M, Levy G, Levin M. Inappropriate sinus tachycardia may be related to an immunologic disorder involving cardiac beta andrenergic receptors. Heart Rhythm. 2006; 3:1182-1186
    1. Jose AD, Collison D. The normal range and determinants of the intrinsic heart rate in man. Cardiovasc Res. 1970; 4:160-167
    1. Marcus B, Gillette PC, Garson A., Jr Intrinsic heart rate in children and young adults: an index of sinus node function isolated from autonomic control. Am Heart J. 1990; 119:911-916
    1. Cappato R, Castelvecchio S, Ricci C, Bianco E, Vitali‐Serdoz L, Gnecchi‐Ruscone T, Pittalis M, De Ambroggi L, Baruscotti M, Gaeta M, Furlanello F, Di Francesco D, Lupo PP. Clinical efficacy of ivabradine in patients with inappropriate sinus tachycardia: a prospective, randomized, placebo‐controlled, double‐blind, crossover evaluation. J Am Coll Cardiol. 2012; 60:1323-1329
    1. Ehlert FA, Goldberger JJ, Brooks R, Miller S, Kadish AH. Persistent inappropriate sinus tachycardia after radiofrequency current catheter modification of the atrioventricular node. Am J Cardiol. 1992; 69:1092-1095
    1. Shen WK. How to manage patients with inappropriate sinus tachycardia. Heart Rhythm. 2005; 2:1015-1019
    1. Benezet‐Mazuecos J, Rubio JM, Farre J, Quinones MA, Sanchez‐Borque P, Macia E. Long‐term outcomes of ivabradine in inappropriate sinus tachycardia patients: appropriate efficacy or inappropriate patients. Pacing Clin Electrophysiol. 2013; 36:830-836
    1. Hersi AS. Potentially new indication of ivabradine: treatment of a patient with postural orthostatic tachycardia syndrome. Open Cardiovasc Med J. 2010; 4:166-167
    1. McDonald C, Frith J, Newton JL. Single centre experience of ivabradine in postural orthostatic tachycardia syndrome. Europace. 2011; 13:427-430
    1. Raj SR, Black BK, Biaggioni I, Paranjape SY, Ramirez M, Dupont WD, Robertson D. Propranolol decreases tachycardia and improves symptoms in the postural tachycardia syndrome: less is more. Circulation. 2009; 120:725-734

Source: PubMed

Sponzoři a spolupracovníci

Zdravotní podmínky

Drogové intervence

3
Předplatit